The stock of Cardinal Health Inc. (NYSE:CAH) increased by $0.09 on Tuesday to finish at $89.83, up 0.10 percent. The last five days have seen an average of 2,300,220 shares of common stock traded. 29 times new highs were reached in the current year, with a gain of $12.96. The average number of shares traded over the last 20 days was 2,597,565, while the average volume over the last 50 days totaled 2,306,988.
CAH stock dropped -1.79% since last month. On 08/23/23, the company’s shares reached a one-month low of $85.11. The stock touched a high of $95.45 on 08/15/23, after rallying from a low of $64.99 in 52 weeks. The price of CAH stock has risen by 16.86% or $12.96 this year, reaching a new high 29 times. Still, the stock price is down -5.89% from the 52-week high.
Insider Transactions
CAH stock investors should be aware that Cardinal Health Inc. (CAH) stock had its last reported insider trading activity 2 days ago on Aug 28. On Aug 28, CEO, Pharmaceutical Segment WEITZMAN DEBORAH sold 6,712 shares at $89.81 each. This transaction resulted in the insider making $602,805. On Aug 18, Scherer Mary C. sold 20,695 shares at a price of US$86.27. After the transaction, the insider now owns 10,649 shares. CEO, Medical Segment Mason Stephen M had earlier sold 37,500 shares on Aug 17 for $87.32 a share. The transaction was completed for $3,274,642.
Valuation Metrics
Cardinal Health Inc. (CAH) has a trailing price-to-earnings (P/E) ratio of 90.65. Beta for the stock is 0.79. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 0.11, and the price-to-cash flow ratio of 9.39.
Company paid $0.5006 per share in dividends, remained unchanged from $0.5006 last year.
Financial Health
For the three months ended June 29, Cardinal Health Inc.’s quick ratio was 0.50, while its current ratio was 1.00, indicating its inability to pay off its debt. As far as profitability goes, gross margin for the trailing twelve months is 3.40% percent. Cardinal Health Inc.’s operating margin stood at 0.40% for the same period. Based on annual data, it had gross profit of $6.89 billion and revenue of $205.01 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. CAH’s return on assets (ROA) during the last 12 months has been 0.60%. There was a 19.00% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was -11.50%.
Earnings Surprise
According to Cardinal Health Inc.’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $53.45 billion, while revenues rose by 11.88% to $50.49 billion. It was predicted that Cardinal Health Inc.’s quarterly earnings would be $1.55, but it ended up being $1.49, beating the consensus by 4.00%. EBITDA was $313.0 million for the quarter. At the end of Cardinal Health Inc.’s most recent quarter ended June 29, its liabilities totaled 46.27 billion, while its total debt was $5.27 billion. Equity owned by shareholders amounts to $250.68 million.
Technical Picture
Here’s a quick look at Cardinal Health Inc.’s (CAH) price momentum from a technical perspective. As of 29 August, the RSI 9-day stood at 54.85%, suggesting the stock is Neutral, with a 31.13% historical volatility rate.
The stochastic %K and %D were 38.24% and 25.67% respectively, while the average true range (ATR) was 1.78. Based on the 14-day stochastic reading of 45.62%, the RSI (14) reading is 50.51%. On the 9-day MACD Oscillator, the stock is at 2.02, and the 14-day reading is at 0.34.
Analyst Ratings
Cardinal Health Inc. (NYSE: CAH) was downgraded by Evercore ISI to a an In-line rating in its latest research report. The stock was previously rated as a an Outperform. Analysts have assigned Cardinal Health Inc. (CAH) an Hold rating. CAH is a stock that is recommended for selling by 0 brokerage firms, while 12 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 1 rate it overweight and 3 others recommend it as a buy.
What is CAH’s price target for the next 12 months?
The current consensus forecast for the stock is between $78.00 and $108.00, with a median target price of $100.00. In analyzing these forecasts, the average price target given by analysts for Cardinal Health Inc. (CAH) is $97.65.
